These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23565471)
21. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients. Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591 [TBL] [Abstract][Full Text] [Related]
22. Efficacy, Safety and Treatment Satisfaction of Glimepiride vs Sitagliptin in Combination with Metformin in Type 2 Diabetes Mellitus. Kumar S; Pathak AK; Saikia D; Kumar A J Clin Diagn Res; 2015 Dec; 9(12):FC07-10. PubMed ID: 26816909 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of sitagliptin and metformin compared with insulin as an initial therapy for newly diagnosed diabetic patients with severe hyperglycaemia. He M; Deng M; Wang J; Fan P; Wang Y; Zhao X; He Y; Shi B; Sui J Exp Ther Med; 2021 Mar; 21(3):217. PubMed ID: 33574913 [TBL] [Abstract][Full Text] [Related]
24. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S Diabetes Obes Metab; 2009 Feb; 11(2):157-66. PubMed ID: 19125777 [TBL] [Abstract][Full Text] [Related]
25. Sitagliptin in type 2 diabetes mellitus: Efficacy after five years of therapy. Derosa G; D'Angelo A; Maffioli P Pharmacol Res; 2015 Oct; 100():127-34. PubMed ID: 26211947 [TBL] [Abstract][Full Text] [Related]
26. Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant. Soliman AR; Fathy A; Khashab S; Shaheen N; Soliman MA Exp Clin Transplant; 2013 Dec; 11(6):494-8. PubMed ID: 24344941 [TBL] [Abstract][Full Text] [Related]
27. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients. Jeon HJ; Oh TK Diabetes Metab J; 2011 Oct; 35(5):529-35. PubMed ID: 22111045 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of sitagliptin compared with sulfonylurea therapy in patients with type 2 diabetes showing inadequately controlled glycosylated hemoglobin with metformin monotherapy: A meta-analysis. Hou L; Zhao T; Liu Y; Zhang Y Exp Ther Med; 2015 Apr; 9(4):1528-1536. PubMed ID: 25780464 [TBL] [Abstract][Full Text] [Related]
29. Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes. Giampietro O; Giampietro C; Bartola LD; Masoni MC; Matteucci E Drug Des Devel Ther; 2013; 7():99-104. PubMed ID: 23439744 [TBL] [Abstract][Full Text] [Related]
30. Effects of sitagliptin as initial therapy in newly diagnosed elderly type 2 diabetics: A randomized controlled study. Xiao X; Cui X; Zhang J; Han Z; Xiao Y; Chen N; Li B; Cheng M; Gao H; Tang K Exp Ther Med; 2016 Nov; 12(5):3002-3008. PubMed ID: 27882107 [TBL] [Abstract][Full Text] [Related]
31. Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitus. Kabadi MU; Kabadi UM Clin Ther; 2004 Jan; 26(1):63-9. PubMed ID: 14996518 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent. Tang YZ; Wang G; Jiang ZH; Yan TT; Chen YJ; Yang M; Meng LL; Zhu YJ; Li CG; Li Z; Yu P; Ni CL Diabetol Metab Syndr; 2015; 7():91. PubMed ID: 26500706 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of vildagliptin and sitagliptin in lowering fasting plasma glucose: Results of a randomized controlled trial. Göke R; Eschenbach P; Dütting ED Diabetes Metab; 2015 Jun; 41(3):244-7. PubMed ID: 25457473 [TBL] [Abstract][Full Text] [Related]
34. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801 [TBL] [Abstract][Full Text] [Related]
35. Effect of sitagliptin and glimepiride on C-reactive protein (CRP) in overweight Type-2 diabetic patients. Hussain M; Rafique MA; Iqbal J; Akhtar L Pak J Med Sci; 2019; 35(2):383-387. PubMed ID: 31086519 [TBL] [Abstract][Full Text] [Related]
36. Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group. Kalra S; Das AK; Baruah MP; Unnikrishnan AG; Dasgupta A; Shah P; Sahay R; Shukla R; Das S; Tiwaskar M; Vijayakumar G; Chawla M; Eliana F; Suastika K; Orabi A; Rahim AAA; Uloko A; Bahendeka S; Abdela AA; Mohammed F; Pathan F; Rahman MH; Afsana F; Selim S; Moosa M; Murad M; Shreshtha PK; Shreshtha D; Giri M; Hussain W; Al-Ani A; Ramaiya K; Singh S; Raza SA; Aye TT; Garusinghe C; Muthukuda D; Weerakkody M; Kahandawa S; Bavuma C; Ruder S; Vanny K; Khanolkar M; Czupryniak L Diabetes Ther; 2019 Oct; 10(5):1577-1593. PubMed ID: 31267358 [TBL] [Abstract][Full Text] [Related]
37. A prescription survey in diabetes assessing metformin use in a tertiary care hospital in Eastern India. Nandy M; Mandal A; Banerjee S; Ray K J Pharmacol Pharmacother; 2012 Jul; 3(3):273-5. PubMed ID: 23129967 [No Abstract] [Full Text] [Related]
38. Safety of canagliflozin in patients with type 2 diabetes. Mikhail N Curr Drug Saf; 2014; 9(2):127-32. PubMed ID: 24446889 [TBL] [Abstract][Full Text] [Related]
39. Teneligliptin for the treatment of type 2 diabetes. Goda M; Kadowaki T Drugs Today (Barc); 2013 Oct; 49(10):615-29. PubMed ID: 24191255 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2). Giorgino F; Benroubi M; Sun JH; Zimmermann AG; Pechtner V Diabetes Care; 2015 Dec; 38(12):2241-9. PubMed ID: 26089386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]